Huff, Murray W.
Western University · Robarts Research Institute
8 papers on CoChatORCID 0000-0002-8976-0692
Most cited papers
- Verified
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia
Johansen, C. T., Wang, J., Lanktree, M. B., Cao, H., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E., et al. (2010) · Nature Genetics
Lipid metabolism and disordersGenetic Associations and Epidemiology
Cited by 437
- Verified
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis
Mulvihill, E. E., Burke, A. C., & Huff, M. W. (2016) · Annual Review of Nutrition
Bioactive Compounds in PlantsPhytochemicals and Antioxidant Activities
Cited by 228
- Verified
An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia
Johansen, C. T., Wang, J., Lanktree, M. B., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E., Schwartz, S. M., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 97
- Verified
ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia
Burke, A. C., & Huff, M. W. (2017) · Current Opinion in Lipidology
Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism
Cited by 91
- Verified · note
Apolipoprotein C-III: Going Back to the Future for a Lipid Drug Target
Huff, M. W., & Hegele, R. A. (2013) · Circulation Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 70
- Verified
Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation
Whitman, S. C., Miller, D. B., Wolfe, B. M., Hegele, R. A., & Huff, M. W. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology
Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases
Cited by 59
- Verified
Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein
Bojic, L. A., Sawyez, C. G., Telford, D. E., Edwards, J. Y., Hegele, R. A., & Huff, M. W. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology
Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism
Cited by 51
- Verified
Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping
Walden, C. C., Huff, M. W., Leiter, L. A., Connelly, P. W., & Hegele, R. A. (1994) · The Journal of Clinical Endocrinology & Metabolism
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free